We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JACS:NYSEJackson Acquisition Company II Analysis

Data as of 2026-04-11 - not real-time

$10.55

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading just above its short‑term support zone, with the 20‑day moving average barely outpacing the 50‑day average, indicating a modest bullish bias. Momentum metrics are neutral‑to‑slightly bearish: the RSI hovers around the mid‑50s and the MACD histogram is marginally negative, while the overall trend is still classified as bullish. Volume has been picking up, reinforcing the short‑term price action, and the beta is effectively zero, suggesting the price moves largely independent of market swings. Market sentiment is at the extreme greed end of the fear‑greed spectrum, which often precedes a short‑term pull‑back.
Fundamentally, the company shows no operating revenue and negative cash flows, with a debt‑to‑equity ratio that is exceptionally high for a shell entity. Valuation multiples are astronomical – the price‑to‑earnings is more than double the industry average and the price‑to‑book ratio is in the thousands, far exceeding any reasonable benchmark. There is no dividend and the balance sheet relies heavily on cash reserves to offset debt, while the return on equity appears decent but is not supported by earnings. These fundamentals, combined with the technical picture, suggest limited upside and heightened downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical trend with support intact
  • Extreme valuation multiples
  • Increasing volume but limited upside

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Persistently negative cash flow
  • High debt‑to‑equity ratio
  • Market sentiment at extreme greed

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • No operating revenue or earnings
  • Astronomical price‑to‑book ratio
  • Potential for value erosion if a merger fails

Key Metrics & Analysis

Financial Health

P/E Ratio34.0
ROE1803.98%
ROA-0.15%
Debt/Equity89.70
P/B Ratio1507.1
Op. Cash Flow$-427590
Free Cash Flow$-298680
Industry P/E17.1

Technical Analysis

TrendBullish
RSI54.3
Support$10.50
Resistance$10.65
MA 20$10.54
MA 50$10.52
MA 200$10.42
MACDBearish
VolumeIncreasing
Fear & Greed Index87.09

Valuation

GradeOvervalued
TypeValue

Risk Assessment

Beta0.01
Volatility3.53%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.